Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v12-FR | Version v4-EN | |
|---|---|---|
| Language | French | English |
| Date Updated | 2024-11-25 | 2024-09-17 |
| Drug Identification Number | 00013579 | 00013579 |
| Brand name | GRAVOL IM | GRAVOL IM |
| Common or Proper name | DIMENHYDRINATE INJECTION | DIMENHYDRINATE INJECTION |
| Company Name | CHURCH & DWIGHT CANADA CORP | CHURCH & DWIGHT CANADA CORP |
| Ingredients | DIMENHYDRINATE | DIMENHYDRINATE |
| Strength(s) | 50MG | 50MG |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | INTRAMUSCULAR INTRAMUSCULAR | INTRAMUSCULAR INTRAMUSCULAR |
| Packaging sizes (GTIN) | (See additional packaging sizes) | (See additional packaging sizes) |
| Additional packaging sizes | 10 X 1 mL | 10 X 1 mL |
| ATC code | R06AA | R06AA |
| ATC description | ||
| Reason for shortage | Other (Please describe in comments) | Other (Please describe in comments) |
| Anticipated start date | 2024-10-04 | 2024-09-16 |
| Actual start date | 2024-10-09 | |
| Estimated end date | 2024-11-22 | 2024-11-11 |
| Actual end date | 2024-11-24 | |
| Shortage status | Resolved | Actual shortage |
| Tier 3 Status | No | No |
| Company comments | Requirements related to complying with good distribution practices | Requirements related to complying with good distribution practices |
| Health Canada comments |